{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:51:26Z","timestamp":1771631486544,"version":"3.50.1"},"reference-count":60,"publisher":"IMR Press","issue":"3","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Integr. Neurosci."],"abstract":"<jats:p>Approximately 1.25 million people in the UK suffer from an eating disorder, yet the treatment options show limited efficacy, warranting the need for novel approaches. This study aimed to investigate the perspectives of people with eating disorders on the use of complementary therapies and psychedelic research and treatment. Two hundred participants with eating disorders took part in this web survey study. The majority of participants (70%) had used a complementary treatment to manage their eating disorder. Participants believed that psychedelic research was worthwhile in the context of a moderate level of concern. The most popular solutions to meet these concerns included providing education around psychedelics and their effects and use in psychiatry and experiencing endorsement from professionals in the area. Moreover, participant responses emphasized the need for a safe, monitored environment and the patient-therapist rapport in the context of psychedelic treatment. The findings are explored concerning future trials of psychedelics as a treatment for eating disorders.<\/jats:p>","DOI":"10.31083\/j.jin2003059","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T08:02:03Z","timestamp":1632988923000},"source":"Crossref","is-referenced-by-count":14,"title":["Perspectives on psychedelic treatment and research in eating disorders: a web-based questionnaire study of people with eating disorders"],"prefix":"10.31083","volume":"20","author":[{"given":"Fiona","family":"Harding","sequence":"first","affiliation":[{"name":"South London and Maudsley NHS Foundation Trust, SE5 8AZ London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Seynaeve","sequence":"first","affiliation":[{"name":"Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College, SE5 8AZ London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Keeler","sequence":"first","affiliation":[{"name":"Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College, SE5 8AZ London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubertus","family":"Himmerich","sequence":"first","affiliation":[{"name":"South London and Maudsley NHS Foundation Trust, SE5 8AZ London, UK"},{"name":"Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College, SE5 8AZ London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Treasure","sequence":"first","affiliation":[{"name":"South London and Maudsley NHS Foundation Trust, SE5 8AZ London, UK"},{"name":"Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College, SE5 8AZ London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Kan","sequence":"first","affiliation":[{"name":"Community Mental Health Team, St Ann\u2019s Hospital, N15 3TH London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"ref1","unstructured":"BEAT. How many people have an eating disorder in the UK? 2020. Available at: https:\/\/www.beateatingdisorders.org.uk\/how-many-people-eating-disorder-uk (Accessed: 8 February 2021)."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Franko DL, Keshaviah A, Eddy KT, Krishna M, Davis MC, Keel PK, et al. A longitudinal investigation of mortality in anorexia nervosa and bulimia nervosa. American Journal of Psychiatry. 2013; 170: 917\u2013925.","DOI":"10.1176\/appi.ajp.2013.12070868"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Eddy KT, Tabri N, Thomas JJ, Murray HB, Keshaviah A, Hastings E, et al. Recovery from anorexia nervosa and bulimia nervosa at 22-year follow-up. Journal of Clinical Psychiatry. 2017; 78: 184\u2013189.","DOI":"10.4088\/JCP.15m10393"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Treasure, J. Willmott D, Ambwani S, Cardi V, Clark Bryan D, Rowlands K, et al. Cognitive interpersonal model for anorexia nervosa revisited: the perpetuating factors that contribute to the development of the severe and enduring illness. Journal of Clinical Medicine. 2020; 9: 630.","DOI":"10.3390\/jcm9030630"},{"key":"ref5","unstructured":"NICE. Eating disorders: recognition and treatment. 2017. Available at: https:\/\/www.nice.org.uk\/guidance\/ng69 (Accessed: 8 February 2021)."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Taylor D, Barnes T, Young A. Maudsley prescribing guidelines. 13th edn. 2009; 667\u2013669.","DOI":"10.3109\/9780203092835"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hay PJ, Touyz S, Sud R. Treatment for severe and enduring anorexia nervosa: a review. Australian and New Zealand Journal of Psychiatry. 2012; 46: 1136\u20131144.","DOI":"10.1177\/0004867412450469"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Berg E, Houtzager L, Vos J, Daemen I, Katsaragaki G, Karyotaki E, et al. Meta\u2010analysis on the efficacy of psychological treatments for anorexia nervosa. European Eating Disorders Review. 2019; 27: 331\u2013351.","DOI":"10.1002\/erv.2683"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"de Vos J, Houtzager L, Katsaragaki G, van de Berg E, Cuijpers P, Dekker J. Meta analysis on the efficacy of pharmacotherapy versus placebo on anorexia nervosa. Journal of Eating Disorders. 2014; 2: 27.","DOI":"10.1186\/PREACCEPT-4411633211333451"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Himmerich H, Joaquim M, Bentley J, Kan C, Dornik J, Treasure J, et al. Psychopharmacological options for adult patients with anorexia nervosa: the patients\u2019 and carers\u2019 perspectives. CNS Spectrums. 2018; 23: 251\u2013252.","DOI":"10.1017\/S1092852917000529"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Halmi KA. Pharmacotherapy and physiological intervention for eating disorders. FOCUS. 2014; 12: 388\u2013393.","DOI":"10.1176\/appi.focus.120401"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Steinhausen H. The outcome of anorexia nervosa in the 20th century. American Journal of Psychiatry. 2002; 159: 1284\u20131293.","DOI":"10.1176\/appi.ajp.159.8.1284"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Dobrescu SR, Dinkler L, Gillberg C, R\u00e5stam M, Gillberg C, Wentz E. Anorexia nervosa: 30-year outcome. British Journal of Psychiatry. 2020; 216: 97\u2013104.","DOI":"10.1192\/bjp.2019.113"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ruiz NAL, Del \u00c1ngel DS, Olgu\u00edn HJ, Silva ML. Neuroprogression: the hidden mechanism of depression. Neuropsychiatric Disease and Treatment. 2018; 14: 2837\u20132845.","DOI":"10.2147\/NDT.S177973"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Nutt D. Psychedelic drugs-a new era in psychiatry? Dialogues in Clinical Neuroscience. 2019; 21: 139\u2013147.","DOI":"10.31887\/DCNS.2019.21.2\/dnutt"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Nichols DE. Psychedelics. Pharmacological Reviews. 2016; 68: 264\u2013355.","DOI":"10.1124\/pr.115.011478"},{"key":"ref17","unstructured":"Naranjo P. El ayahuasca en la arqueolog\u00eda ecuatoriana. Am\u00e9rica ind\u00edgena. 1986; 46: 117\u2013127. (In Spanish)"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Guzm\u00e1n G. The hallucinogenic mushrooms: diversity, traditions, use and abuse with special reference to the genus psilocybe. Fungi from Different Environments. 2019; 256\u2013277.","DOI":"10.1201\/9780429061653-11"},{"key":"ref19","unstructured":"Samorini, G. The oldest representations of hallucinogenic mushrooms in the world (Sahara Desert, 9000\u20137000 B. P.). Integration. 2016; 2: 69\u201378."},{"key":"ref20","unstructured":"Hofmann A. LSD: my problem child. Antioch Review. Washington D. C.: McGraw-Hill Book Company. 1980."},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, et al. Psychedelics and the essential importance of context. Journal of Psychopharmacology. 2018; 32: 725\u2013731.","DOI":"10.1177\/0269881118754710"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA. Psychedelic treatments for psychiatric disorders: a systematic review and thematic synthesis of patient experiences in qualitative studies. CNS Drugs. 2020; 34: 925\u2013946.","DOI":"10.1007\/s40263-020-00748-y"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Holoyda B. Psychedelic psychiatry: preparing for novel treatments involving altered states of consciousness. Psychiatric Services. 2020; 71: 1297\u20131299.","DOI":"10.1176\/appi.ps.202000213"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Muttoni S, Ardissino M, John C. Classical psychedelics for the treatment of depression and anxiety: a systematic review. Journal of Affective Disorders. 2019; 258: 11\u201324.","DOI":"10.1016\/j.jad.2019.07.076"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Dos Santos RG, Bouso JC, Alc\u00e1zar-C\u00f3rcoles M\u00c1, Hallak JEC. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Review of Clinical Pharmacology. 2018; 11: 889\u2013902.","DOI":"10.1080\/17512433.2018.1511424"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Lee EE, Della Selva MP, Liu A, Himelhoch S. Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis. General Hospital Psychiatry. 2015; 37: 178\u2013184.","DOI":"10.1016\/j.genhosppsych.2015.01.003"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Mills IH, Park GR, Manara AR, Merriman RJ. Treatment of compulsive behaviour in eating disorders with intermittent ketamine infusions. Monthly Journal of the Association of Physicians. 1998; 91: 493\u2013503.","DOI":"10.1093\/qjmed\/91.7.493"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Walsh Z, Mollaahmetoglu M, Rootman J, Goslof S, Keeler J, Jackson A, et al. Ketamine for the treatment of mental health and substance use disorders: a comprehensive systematic review. Submitted to Frontiers in Psychiatry. 2021.","DOI":"10.1192\/bjo.2021.1061"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Lafrance A, Loizaga-Velder A, Fletcher J, Renelli M, Files N, Tupper KW. Nourishing the spirit: exploratory research on ayahuasca experiences along the continuum of recovery from eating disorders. Journal of Psychoactive Drugs. 2017; 49: 427\u2013435.","DOI":"10.1080\/02791072.2017.1361559"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Renelli M, Fletcher J, Tupper KW, Files N, Loizaga-Velder A, Lafrance A. An exploratory study of experiences with conventional eating disorder treatment and ceremonial ayahuasca for the healing of eating disorders. Eating and Weight Disorders. 2020; 25: 437\u2013444.","DOI":"10.1007\/s40519-018-0619-6"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Spriggs MJ, Kettner H, Carhart-Harris RL. Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder. Eating and Weight Disorders. 2020; 26: 1265\u20131270.","DOI":"10.1007\/s40519-020-01000-8"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Foldi CJ, Liknaitzky P, Williams M, Oldfield BJ. Rethinking therapeutic strategies for anorexia nervosa: insights from psychedelic medicine and animal models. Frontiers in Neuroscience. 2020; 14: 43.","DOI":"10.3389\/fnins.2020.00043"},{"key":"ref33","unstructured":"Qualtrics. 2020. Available at: www.qualtrics.com (Accessed: 1 April 2020)."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. Journal of Psychosomatic Research. 2006; 60: 631\u2013637.","DOI":"10.1016\/j.jpsychores.2005.10.020"},{"key":"ref35","unstructured":"RCoreTeam. R: a language and environment for statistical computing. r foundation for statistical computing. 2020. Available at: https:\/\/www.R\u2013project.org\/ (Accessed: 16 April 2020)."},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Dessain A, Bentley J, Treasure J, Schmidt U, Himmerich H. Patients\u2019 and carers\u2019 perspectives of psychopharmacological interventions targeting anorexia nervosa symptoms. Anorexia and Bulimia Nervosa. 2019; 103.","DOI":"10.5772\/intechopen.86083"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Scharmer C, Altman BR, Donahue JM, Anderson DA, Earleywine M. Expectancies about the effects of cannabis use on eating disorder symptoms. Substance Use & Misuse. 2020; 55: 1825\u20131833.","DOI":"10.1080\/10826084.2020.1766503"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Schifano F, Napoletano F, Chiappini S, Orsolini L, Guirguis A, Corkery JM, et al. New psychoactive substances (NPS), psychedelic experiences and dissociation: clinical and clinical pharmacological issues. Current Addiction Reports. 2019; 6: 140\u2013152.","DOI":"10.1007\/s40429-019-00249-z"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Winkelman M. Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca. Current Drug Abuse Reviews. 2014; 7: 101\u2013116.","DOI":"10.2174\/1874473708666150107120011"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Nowacka A, Borczyk M. Ketamine applications beyond anesthesia\u2014 a literature review. European Journal of Pharmacology. 2019; 860: 172547.","DOI":"10.1016\/j.ejphar.2019.172547"},{"key":"ref41","unstructured":"Home Office for National Statistics. Drugs misuse: findings from the 2018\/19 crime survey for England and Wales. Available at: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/832533\/drug-misuse-2019-hosb2119.pdf (Accessed: 8 February 2021)."},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, et al. Pilot study of psilocybin treatment for anxiety in patients with advanced\u2013stage cancer. Archives of General Psychiatry. 2011; 68: 71\u201378.","DOI":"10.1001\/archgenpsychiatry.2010.116"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, et al. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life\u2014threatening cancer: a randomized controlled trial. Journal of Psychopharmacology. 2016; 30: 1165\u20131180.","DOI":"10.1177\/0269881116675512"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Fotiou E, Gearin AK. Purging and the body in the therapeutic use of ayahuasca. Social Science & Medicine. 2019; 239: 112532.","DOI":"10.1016\/j.socscimed.2019.112532"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical\u2014type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. 2006; 187: 268\u2013292.","DOI":"10.1007\/s00213-006-0457-5"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Carhart-Harris RL, Nutt DJ. Serotonin and brain function: a tale of two receptors. Journal of Psychopharmacology. 2017; 31: 1091\u20131120.","DOI":"10.1177\/0269881117725915"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Gardner J, Carter A, O\u2019Brien K, Seear K. Psychedelic-assisted therapies: the past, and the need to move forward responsibly. International Journal of Drug Policy. 2019; 70: 94\u201398.","DOI":"10.1016\/j.drugpo.2019.05.019"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Dejong H, Broadbent H, Schmidt U. A systematic review of dropout from treatment in outpatients with anorexia nervosa. the International Journal of Eating Disorders. 2012; 45: 635\u2013647.","DOI":"10.1002\/eat.20956"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Hartogsohn I. Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology. Journal of Psychopharmacology. 2016; 30: 1259\u20131267.","DOI":"10.1177\/0269881116677852"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Barrett FS, Johnson MW, Griffiths RR. Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personality and Individual Differences. 2017; 117: 155\u2013160.","DOI":"10.1016\/j.paid.2017.06.004"},{"key":"ref51","unstructured":"Comet initiative. 2020. Available at: https:\/\/comet\u2013initiative.org\/ (Accessed: 8 February 2021)."},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Ahn J, Lee J, Jung Y. Predictors of suicide attempts in individuals with eating disorders. suicide and life\u2014threatening behavior. 2019; 49: 789\u2013797.","DOI":"10.1111\/sltb.12477"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Ulfvebrand S, Birgeg\u00e5rd A, Norring C, H\u00f6gdahl L, von Hausswolff-Juhlin Y. Psychiatric comorbidity in women and men with eating disorders results from a large clinical database. Psychiatry Research. 2015; 230: 294\u2013299.","DOI":"10.1016\/j.psychres.2015.09.008"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Black N, Varaganum M, Hutchings A. Relationship between patient reported experience (PREMs) and patient reported outcomes (PROMs) in elective surgery. BMJ Quality Safety. 2015; 23: 534\u2013542.","DOI":"10.1136\/bmjqs-2013-002707"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Mosler F, Priebe S, Bird V. Routine measurement of satisfaction with life and treatment aspects in mental health patients\u2014the DIALOG scale in east London. BMC Health Services Research. 2020; 20: 1020.","DOI":"10.1186\/s12913-020-05840-z"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Nutt D, Erritzoe D, Carhart-Harris R. Psychedelic psychiatry\u2019s brave new world. Cell. 2020; 181: 24\u201328.","DOI":"10.1016\/j.cell.2020.03.020"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Mithoefer MC, Grob CS, Brewerton TD. Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Lancet. Psychiatry. 2016; 3: 481\u2013488.","DOI":"10.1016\/S2215-0366(15)00576-3"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, et al. The hidden therapist: evidence for a central role of music in psychedelic therapy. Psychopharmacology. 2018; 235: 505\u2013519.","DOI":"10.1007\/s00213-017-4820-5"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Gastaldon C, Raschi E, Kane J, Barbui C, Schoretsanitis G. Post-Marketing safety concerns with esketamine: a disproportionality analysis of spontaneous reports submitted to the FDA adverse event reporting system. Psychotherapy and Psychosomatics. 2021; 90: 41\u201348.","DOI":"10.1159\/000510703"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Hoek HW. Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Current Opinion in Psychiatry. 2006; 19: 389\u2013394.","DOI":"10.1097\/01.yco.0000228759.95237.78"}],"container-title":["Journal of Integrative Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/20\/3\/10.31083\/j.jin2003059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T15:19:29Z","timestamp":1732720769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/JIN\/20\/3\/10.31083\/j.jin2003059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["1632962191325-1116268835"],"URL":"https:\/\/doi.org\/10.31083\/j.jin2003059","relation":{},"ISSN":["0219-6352","1757-448X"],"issn-type":[{"value":"0219-6352","type":"print"},{"value":"1757-448X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"article-number":"551"}}